Clinical Trial Update: A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007) [Phase 3]

View source ↗

Summary

A Phase 3 study is investigating the efficacy and safety of tezepelumab in adults with moderate to very severe chronic obstructive pulmonary disease and is curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Tezepelumab (tezepelumab)

Snippet

Sponsor: AstraZeneca | Conditions: Chronic Obstructive Pulmonary Disease (COPD) | Phase 3 | Status: RECRUITING